Cardiovascular Effects of Epinephrine During Experimental Hypothermia (32°C) With Spontaneous Circulation in an Intact Porcine Model by Mohyuddin, Rizwan et al.
Frontiers in Physiology | www.frontiersin.org 1 September 2021 | Volume 12 | Article 718667
ORIGINAL RESEARCH
published: 06 September 2021
doi: 10.3389/fphys.2021.718667
Edited by: 
Bruno Moreira Silva, 




Centre Hospitalier Universitaire de 
Grenoble, France
Paweł Podsiadło, 





This article was submitted to 
Clinical and Translational Physiology, 
a section of the journal 
Frontiers in Physiology
Received: 01 June 2021
Accepted: 25 June 2021
Published: 06 September 2021
Citation:
Mohyuddin R, Dietrichs ES, 
Sundaram P, Kondratiev T, 
Figenschou MF, Sieck GC and 
Tveita T (2021) Cardiovascular 
Effects of Epinephrine During 
Experimental Hypothermia (32°C) 




Cardiovascular Effects of 
Epinephrine During Experimental 
Hypothermia (32°C) With 
Spontaneous Circulation in an Intact 
Porcine Model
Rizwan Mohyuddin 1, Erik Sveberg Dietrichs 2,3, Predip Sundaram 1, Timofey Kondratiev 1, 
Marie Fjellanger Figenschou 1,4, Gary C. Sieck 5 and Torkjel Tveita 1,4,5*
1 Anesthesia and Critical Care Research Group, Department of Clinical Medicine, UiT, The Arctic University of Norway, 
Tromsø, Norway, 2 Experimental and Clinical Pharmacology Research Group, Department of Medical Biology, UiT, The Arctic 
University of Norway, Tromsø, Norway, 3 Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway, 4 Division 
of Surgical Medicine and Intensive Care, University Hospital of North Norway, Tromsø, Norway, 5 Department of Physiology 
and Biomedical Engineering, Mayo Clinic, Rochester, MI, United States
Aims: Rewarming from accidental hypothermia and therapeutic temperature management 
could be complicated by cardiac dysfunction. Although pharmacologic support is often 
applied when rewarming these patients, updated treatment recommendations are lacking. 
There is an underlying deficiency of clinical and experimental data to support such 
interventions and this prevents the development of clinical guidelines. Accordingly, 
we explored the clinical effects of epinephrine during hypothermic conditions.
Materials and methods: Anesthetized pigs were immersion cooled to 32°C. 
Predetermined variables were compared at temperature/time-point baseline, after receiving 
30 ng/kg/min and 90 ng/kg/min epinephrine infusions: (1) before and during hypothermia 
at 32°C, and after rewarming to 38°C (n = 7) and (2) a time-matched (5 h) normothermic 
control group (n = 5).
Results: At 32°C, both stroke volume and cardiac output were elevated after 30 ng/kg/
min administration, while systemic vascular resistance was reduced after 90 ng/kg/min. 
Epinephrine infusion did not alter blood flow in observed organs, except small intestine 
flow, and global O2 extraction rate was significantly reduced in response to 90 ng/kg/min 
infusion. Electrocardiographic measurements were unaffected by epinephrine infusion.
Conclusion: Administration of both 30 ng/kg/min and 90 ng/kg/min at 32°C had a 
positive inotropic effect and reduced afterload. We  found no evidence of increased 
pro-arrhythmic activity after epinephrine infusion in hypothermic pigs. Our experiment 
therefore suggests that β₁-receptor stimulation with epinephrine could be a favorable 
strategy for providing cardiovascular support in hypothermic patients, at core 
temperatures >32°C.
Keywords: cardiovascular dysfunction, vasopressor, targeted temperature management, rewarming, electrophysiology, 
ventricular arrhythmias
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INTRODUCTION
Guidelines for targeted temperature management (TTM) and 
therapeutic hypothermia recommend reducing core temperatures 
to 36–32°C for neuroprotection in comatose patients after 
resuscitation from sudden cardiac arrest (Nolan et  al., 2015). 
However, after return of spontaneous circulation, these patients 
often suffer acute heart failure and need inotropic drugs to 
support inadequate circulatory function (Bernard et  al., 2002; 
Safar and Kochanek, 2002).
Temperatures similar to those used in TTM are regularly 
observed in victims of accidental hypothermia. These patients 
often display hypothermia-induced cardiac dysfunction (HCD), 
associated with reduced cardiac output (CO) during 
rewarming. In order to elevate low CO, epinephrine has 
been used in experimental treatment of HCD (Kondratiev 
and Tveita, 2006; Tveita and Sieck, 2011). Despite its frequent 
use as an inotropic agent, little is known about the clinical 
effects of epinephrine (Epi) in TTM patients and victims 
of accidental hypothermia. Accordingly, guidelines describing 
the use of inotropic drugs to support cardiovascular function 
at low core temperatures are lacking evidence-based 
information. Thus, it is vital to acquire more translational 
data to understand the pharmacological properties of Epi 
at low core temperatures.
During normal core temperatures, Epi works as a β-receptor 
agonist and increases cardiac contractility via a G protein – 
protein kinase A (PKA) signaling pathway, by increasing cyclic 
adenosine monophosphate (cAMP). In low concentrations, Epi 
causes peripheral vasodilation, through β2-stimulation and 
elevated cAMP in smooth muscle. At higher concentrations 
β-adrenergic selectivity is lost, with increasing α-receptor 
stimulation, causing vasoconstriction (Dietrichs et  al., 2016). 
Several of our in vivo rat studies have shown that Epi failed 
to elevate stroke volume (SV) and cardiac out (CO) during 
hypothermia and after rewarming. Moreover, it has been 
reported that inotropic effect of Epi decreases below 34°C, 
due to relative higher α-receptor than β-receptor response, 
shown through elevated total peripheral resistance (Kondratiev 
and Tveita, 2006; Tveita and Sieck, 2011; Dietrichs et al., 2016). 
We  found that low dose (0.125  μg/min) Epi compared to 
high dose (1.25  μg/min) gave positive inotropic effect during 
hypothermia (28°C; Tveita and Sieck, 2011). These results in 
a rat model indicate that hypothermia exerts a negative impact 
on cardiac inotropy, mediated by the β1-receptor pathway, 
causing a reduced therapeutic interval for beneficial effects of 
Epi (Dietrichs et  al., 2016).
Fundamental species-dependent differences exist in physiology 
and metabolism, including pharmacokinetics and 
pharmacodynamics of different drugs (Toutain et  al., 2010). 
In this study, a pig model was chosen due to its close morphologic 
and physiologic relationship with humans, giving a higher 
translational potential than previous findings in rodents (Swindle, 
1998). Accordingly, the present study aimed to assess whether 
a low (30  ng/kg/min) and a high (90  ng/kg/min) doses of 
Epi provide inotropic support at low core temperatures, relevant 
in TTM and accidental hypothermia. For this purpose, 
we monitored global O2 delivery (DO2), O2 consumption (VO2), 
and organ blood flow, as well as cardiac electrophysiology 
during hypothermia (32°C) and rewarming to 38°C, using an 




The Norwegian National Animal Research Authority approved 
the experimental protocol. The experiments were conducted 
in accordance with the Norwegian Regulation on Animal 
Experimentation and the European Contention for the Protection 
of Vertebrate Animals used for Experimental and Other Scientific 
Purposes (European Council, ETS no. 170). The animals received 
humane care in accordance to the Norwegian Animal Welfare Act.
Experimental Animals
Fourteen castrated juvenile male NOROC stock pigs weighing 
27  ±  5  kg were acclimated to the animal department for 
3–5  days before experiments. Two pigs were used for pilot 
experiments to determine expedient dose of Epi.
Anesthesia and Instrumentation
Methods for anesthesia, instrumentation, monitoring, 
sampling, data analysis, and calculations used in the porcine 
animal model for this study were previously described in 
detail (Valkov et  al., 2019). Briefly, after an overnight fast, 
the pigs were premedicated by i.m. injections of 20  mg/kg 
ketamine, 30 mg midazolam, and 1 mg of atropine. Anesthesia 
was induced by intravenous injection of pentobarbital 10 mg/
kg and fentanyl 0.01  mg/kg. The pigs were tracheostomized 
and intubated with a 7.0  mm Portex tracheal tube. They 
were ventilated with end-expiratory pressure of 0  cm H2O, 
FiO2 0.21 (Siemens Servo 900D, Solna, Sweden). Arterial, 
central venous, mixed venous, and cerebral venous were 
sampled and analyzed (ABL800 FLEX, Radiometer medical, 
Copenhagen, Denmark) to confirm adequate ventilation and 
calculate global and cerebral O2 transport. Anesthesia was 
maintained by continuous intravenous infusion of 
pentobarbital 4  mg/kg/h, fentanyl 0.02  mg/kg/h, and 
midazolam 0.3  mg/kg/h along with infusion of 9  ml/kg/h 
Ringer-acetate throughout the experiment. Euthanasia was 
performed by i.v. injection of 1  g pentobarbital and 20  ml 
KCl (1 mmol/ml) at the end of experiment. Medical infusions 
were provided through an 18  Ga central venous line in the 
right jugular vein. Cerebral venous blood gases were obtained 
from a retrograde 18  Ga central venous line in the jugular 
bulb, introduced through the left internal jugular vein 
(7–10 cm). Pulmonary artery pressure, central venous pressure 
(CVP), core temperature, and CO measurements were enabled 
via a 7.5 Fr Swan-Ganz catheter (Edwards Lifesciences, 
Irvine, United  States) in the pulmonary trunk through an 
8.5 Fr Intro-Flex introducer (Intro-Flex, Edwards Lifesciences, 
Irvine, United  States) in the left femoral vein. CO was 
Mohyuddin et al. Effects of Epinephrine During Experimental Hypothermia
Frontiers in Physiology | www.frontiersin.org 3 September 2021 | Volume 12 | Article 718667
measured by thermodilution using a CO-monitor (Vigilance, 
Edwards Lifesciences, Irvine, United  States). For preload 
reduction, a 7 Fr Fogarty catheter (Edwards Lifesciences, 
Irvine, United  States) was placed in the inferior vena cava 
via an 8.5 Fr introducer in the right femoral vein. A 7 Fr 
pressure-volume (PV) catheter (Ventri-Cath-507, Millar 
Instruments, Huston, TX, United  States) was placed in the 
left ventricle via a 10 Fr Super Arrow-Flex introducer (Arrow, 
Reading, United  States) in the right carotid artery. A 7.5 
Fr Swan-Ganz catheter was lead through an 8 Fr introducer 
(Super Arrow-Flex PSI Set, Arrow, Reading, United  States) 
in the left femoral artery and positioned in the aortic arch 
for measurement of blood pressure, sampling of blood for 
arterial blood gases and microspheres reference sampling. 
Injections of stable isotope labeled microspheres were 
performed via a 6 Fr pigtail catheter (Cordis Corporation, 
Miami, FL, United  States) positioned in the left ventricle 
via an 8 Fr introducer through the right femoral artery. 
All animals received 5000  IU heparin after instrumentation. 
A 16 Fr Foley catheter (Teleflex Medical, Perak, Malaysia) 
was introduced via a lower abdominal incision for continuous 
monitoring of urinary output.
Experimental Protocol
Following surgery, animals were allowed to rest for 30  min 
before experiments started. To assess the appropriate dose of 
Epi, a pilot experiment was performed using two pigs. One 
pig received Epi infusions at normothermia in doses of 15, 
30, 45, 60, 75, 90, 105, and 120  ng/kg/min, while monitoring 
HR, MAP, CVP, and CO. A 25–30% increase in CO was 
determined as a target for the first Epi dose (E1), whereas 
the target for the second Epi dose (E2) was inducing a maximal 
increase of CO. The selected doses were administered again 
after the initial tests to test the reproducibility of the results. 
The second pig was cooled to 32°C, and Epi doses of 30, 75, 
and 90  ng/kg/min were administered to test effect on CO. 
From these pilot experiments, Epi doses of 30 and 90  ng/kg/
min were chosen.
Twelve animals were divided into two groups: normothermic 
(NT group, n  =  5) and hypothermic (HT group, n  =  7). 
Sample size was calculated using power analysis. In both 
groups, data were assessed at three different time points. For 
the NT group recordings were performed at baseline after 
initial stabilization, and then after 3  h and 5  h at 38°C 
(Figure  1). For the HT group, recordings were performed at 
38°C baseline, and then after 30  min and 3?? at 32°C (3  h) 
and also following rewarming to 38°C (5  h). At each time 
period, three samples were obtained as: baseline before starting 
Epi infusion (E0), during 30  ng/kg/min Epi infusion (E1), 
and during 90 ng/kg/min Epi infusion (E2). Each Epi infusion 
continued for at least 5  min before recording was started, 
and lasted 15–20  min. All hemodynamic data were recorded 
using a digital acquisition system (PowerLab 16/35, 
ADInstruments, Bella Vista, Australia and MPVS Ultra PV 
unit, Millar Instruments, Huston, TX, United States) and were 
analyzed using Lab Chart Pro 8 software (ADInstruments, 
Bella Vista, Australia).
Temperature Regulation
Core body temperature was monitored via a thermistor 
positioned at the tip of the thermodilution catheter positioned 
in the pulmonary artery. Animals in the HT group were 
cooled by circulating iced water in a reservoir mounted to 
the top of the operating table with the animals placed in 
a supine position, leaving the dorsal 2/3 of the body 
submerged. As blood temperature reached 32°C, water was 
drained from the reservoir and temperature stabilized at 
32  ±  1°C, which was chosen due to this temperature being 
the lower end of therapeutic temperature management in 
comatose survivors of cardiac arrest. For rewarming, the 
reservoir was circulated with tap water at a temperature of 
38–40°C.
Regional Blood Flow
Regional blood flow was estimated using method of neutron 
activation of stable isotope labeled microspheres (BioPAL Inc., 
Worchester, MA, United  States) proposed by Reinhardt et  al. 
(2001) as a high-sensitive and reliable method for measuring 
of regional blood flow in intact tissue. This method was 
refined to use in our animal model as described in detail 
by Valkov et  al. (2019).
At every data sampling time point an injection of ∼ 106 
microspheres, of different specificity, was given through a fluid-
filled pigtail catheter placed in the left ventricle. At the same 
time, a reference blood sample was drawn from the aortic 
arch using a withdrawal pump set at a fixed sample rate 
(5  ml  min−1) for 2  min (New Era Pump Systems, Inc., 
Farmingdale, NY, United  States). Each reference blood sample, 
with the predetermined type of microsphere in accordance 
with the data collection point, was collected in 20  ml sample 
vials. The syringe was rinsed with “sansSaLine” medium (BioPAL, 
Inc.) to secure removal of microspheres attached to the wall. 
Reference blood samples were centrifuged twice with “sansSaLine” 
FIGURE 1 | Experimental protocol. NT – time-matched normothermic group, 
kept at 38°C for 5 h (n = 5); HT – hypothermic group, cooled to 32°C and 
rewarmed back to 38°C (n = 7); E0 – no epinephrine; E1 – epinephrine, 
30 ng/kg/min; and E2 – epinephrine, 90 ng/kg/min.
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to remove sodium and chloride together with the supernatant 
to improve the signal-to-noise ratio of the sample. After the 
end of the experiment, animals were killed, and organ tissue 
samples were taken from the same locations in all animals 
and rinsed with “sansSaLine” to remove surface blood and 
other potential contaminants. Both reference blood samples 
and organ tissue samples were dried in an oven (70°C overnight). 
After processing, reference blood samples and tissue samples 
were analyzed at the BioPAL laboratory for specific activity. 
Tissue samples for evaluation of regional blood flow were taken 
from the heart, brain, kidneys, liver, stomach, and small intestine. 
Determination of regional tissue blood flow (expressed in 
milliliters per minute per gram) was calculated using the 
following equation: Q Tis Q Ref gdpm ref dpm= ×( ) ×( )/ , where 
Q is blood flow in milliliters per minute, Tisdpm is the number 
of radioactive decays in the tissue sample in decays per minute, 
Qref is the reference flow rate in milliliters per minute, Refdpm 
is the number of radioactive decays in the reference blood 
sample in decays per minute, and g is weight of the tissue 
sample in grams (Valkov et  al., 2019).
Hemodynamic Variables, Global and 
Cerebral O2 Transport, and O2 Extraction 
Rate
Left ventricular pressure was measured by a pressure transducer 
on the tip of the PV catheter. Left ventricular contractility was 
assessed by occluding the inferior vena cava with an inflatable 
balloon. At each data sampling point, the balloon was inflated 
to obtain different levels of mechanical work. To relate the 
raw measurement to an estimate of actual volume, transthoracic 
echocardiographic measurements (parasternal short axis view) 
of end diastolic diameter and end systolic diameter were obtained 
























, left ventricular end diastolic
 
volume (EDV) and end systolic volume were calculated. The 
same operator conducted all echocardiographic measurements.
CO values were obtained from thermodilution data. Stroke 
volume (SV) was calculated as: SV  =  CO/HR. O2 content 
(ContO2) values in arterial, mixed venous, and jugular bulb 
samples were calculated according to the formula: 
ContO sO Hb pO2 2
2
21 34 10 0 023= × × ×( )( )+ ×( )−. . , where sO2
 
is blood O2 saturation (%) and Hb is hemoglobin (ml/dl). 
Global DO2 was calculated as the product of CO and arterial 
ContO2 per kg body weight. Global VO2 was calculated as 
the product of CO and the difference between arterial and 
mixed venous ContO2 per kg body weight. Cerebral DO2 was 
calculated as a product of arterial ContO2 and cerebral blood 
flow (CBF). CBF was estimated using the average flow of the 
five cerebral samples (right and left temporal, right and left 
cerebellum, and hippocampus) using the regional blood flow 
estimation technique. Cerebral VO2 was calculated as a product 
of difference between arterial and jugular bulb ContO2 and 
CBF. Global and cerebral O2 extraction rate (O2 ER) was 
calculated as the ratio of corresponding VO2 to DO2 values.
Electrocardiogram
Internal resultant ECG signals from the conductance catheter 
were used. The first 4–5 beats in steady state at each recording 
point were averaged and analyzed using Lab Chart Pro 8 
software. QT interval was corrected for HR using Bazett’s 
formula (QTc). QRS/QTc was calculated according to a recent 
publication relating this parameter to risk for hypothermia-
induced cardiac arrest (Dietrichs et  al., 2020a,b).
Statistics
Sample size was calculated using power analysis. The results 
for blood flow and O2 transport are presented as means ± SD. 
The results for hemodynamic variables and ECG intervals 
are presented as median and percentiles. Data distribution 
was assessed using Shapiro-Wilk test. Dependent on data 
distribution, one-way RM ANOVA for normal distributed 
data or RM ANOVA on ranks for non-normal distributed 
data, was used to compare values within groups. If the F 
value was greater than critical, post-hoc tests were used to 
obtain p values. Tukey’s test was used for pairwise multiple 
comparison of corresponding values before and during 
epinephrine infusions within groups. Dunnett’s test was used 
to compare baseline values at 38°C to baseline values before 
Epi infusion after 3–5  h (NT group) and at 32–38°C after 
rewarming (HT group). The values of p < 0.05 were considered 
statistically significant.
RESULTS
Cooling and Rewarming Rates
All animals survived the experimental protocol. Cooling from 
38°C to 32°C was carried out with a cooling rate of 4°C/h, 
while the rewarming rate was 4.5°C/h.
Responses to Epi Infusion in NT and HT 
Groups at 38°C Baseline
Hemodynamics
Compared to baseline values (before Epi infusion), hemodynamic 
responses were identical in the two groups (Figures  2–4). A 
significant increase in HR was observed only in response to 
90  ng/kg/min, while SV and CO increased significantly in 
response to 30  ng/kg/mg. MAP and left ventricular systolic 
pressure (LVSP) remained unchanged, whereas SVR was 
significantly reduced in response to 30 ng/kg/min. Both maximum 
rate of LV pressure rise (dP/dtmax) and preload recruitable stroke 
work (PRSW) increased in response to 90  ng/kg/min.
O2 Transport
A similar increase in global DO2 was measured in both groups 
(Figure  5). Global DO2 increased in response to 30  ng/kg/
min and was further increased by 90  ng/kg/min. Global VO2 
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remained unchanged. Global O2 ER was well below the critical 
value (0.7). A significant reduction was observed in response 
to 90  ng/kg/min.
Organ Blood Flow
Epi infusion did not result in any significant changes in 




FIGURE 2 | Hemodynamic variables. (A,B) HR, heart rate; (C,D) CO, cardiac output; and (E,F) SV, stroke volume. N = 5 (NT group, left column) and n = 7 (HT group, 
right column). E0 – before epinephrine infusion, E1 – epinephrine infusion 30 ng/kg/min, E2 – epinephrine infusion 90 ng/kg/min, and RW – rewarming. Data are presented 
as vertical boxes with median (solid line), mean (dashed line), and interquartile range with 10th and 90th percentile error bars. Significance is indicated by: * – compared 
with corresponding E0 and # – compared with corresponding E1 (30 ng/kg/min). Level of significance: p < 0.05.
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organs, except small intestine flow at 32°C (not shown; 
Figures  6, 7). Some blood flow changes occurred in the 
cerebellum, hippocampus, and heart in response to 
Epi infusion. These occurred irregularly and were 
not always in a dose-dependent pattern. Importantly, blood 




FIGURE 3 | Hemodynamic variables (cont.). (A,B) MAP, mean arterial pressure; (C,D) LVSP, left ventricular systolic pressure; and (E,F) SVR, systemic vascular 
resistance. N = 5 (NT group, left column) and n = 7 (HT group, right column). E0 – before epinephrine infusion, E1 – epinephrine infusion 30 ng/kg/min, E2 – 
epinephrine infusion 90 ng/kg/min, and RW – rewarming. Data are presented as vertical boxes with median (solid line), mean (dashed line), and interquartile range 
with 10th and 90th percentile error bars. Significance is indicated by: * – compared with corresponding E0, # – compared with corresponding E1 (30 ng/kg/min), and 
§ – compared with absolute (0 h) baseline (E0). Level of significance: p < 0.05.
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infusion, except for hippocampal blood flow was reduced 
in the NT group in response to 90  ng/kg/min compared to 
30  ng/kg/min. Kidney blood flow was increased after 
90  ng/kg/min.
Electrocardiogram
Epi infusions did not change duration of QTc intervals, or 
QRS/QTc ratio (Figure  8). QRS interval increased in the HT 




FIGURE 4 | Hemodynamic variables (cont.). (A,B) dP/dtmax, maximum rate of LV pressure rise; (C,D) dP/dtmin, maximum rate of LV pressure decline; and (E,F) 
PRSW, preload recruitable stroke work. N = 5 (NT group, left column) and n = 7 (HT group, right column). E0 – before epinephrine infusion, E1 – epinephrine infusion 
30 ng/kg/min, E2 – epinephrine infusion 90 ng/kg/min, and RW – rewarming. Data are presented as vertical boxes with median (solid line), mean (dashed line), and 
interquartile range with 10th and 90th percentile error bars. Significance is indicated by: * – compared with corresponding E0, # – compared with corresponding E1 
(30 ng/kg/min), and § – compared with absolute (0 h) baseline (E0). Level of significance: p < 0.05.
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Responses to Epi Infusion in NT Group at 
38°C After 3 h and HT Group at 32°C After 
3 h
Hemodynamic Variables
For the majority of hemodynamic variables, cooling did 
not induce significant changes between NT baseline and 
32°C (Figures  2–4). Exceptions were MAP and dP/dtmin. 
Neither HR nor MAP was responsive to Epi infusion. In 
the HT group, LVSP increased during 90  ng/kg/min and 
CO was elevated in response to 30  ng/kg/min. SV was 
increased by 30  ng/kg/min in the HT group but only by 
90 ng/kg/min in the NT group. Likewise, Epi dose-dependent 
reduction of SVR was observed in NT group, while in 




FIGURE 5 | Oxygen transport. (A,B) Global oxygen delivery, DO2 and consumption, VO2; (C,D) cerebral oxygen delivery, DO2 and consumption, VO2; and (E,F) 
global and cerebral O2 extraction ratio, O2 ER. N = 5 (NT group, left column) and n = 7 (HT group, right column). E0 – before epinephrine infusion, E1 – epinephrine 
infusion 30 ng/kg/min, E2 – epinephrine infusion 90 ng/kg/min, and RW – rewarming. Data are presented as means and standard deviation. Significance is indicated 
by: * – compared with corresponding E0, # – compared with corresponding E1 (30 ng/kg/min), and § – compared with absolute (0 h) baseline (E0). Level of 
significance: p < 0.05.
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to 90  ng/kg/min. Effect of Epi infusion on dP/dtmax was 
similar in both groups, with increase in response to 30  ng/
kg/min. dP/dtmin was changed only in the NT group after 
90  ng/kg/min. PRSW increased in response to 30  ng/kg/
min in the NT group, while only elevated by 90  ng/kg/min 




FIGURE 6 | Organ blood flow. (A,B) Brain temporal lobe, (C,D) cerebellum, and (E,F) hippocampus. N = 5 (NT group, left column) and n = 7 (HT group, right 
column). E0 – before epinephrine infusion, E1 – epinephrine infusion 30 ng/kg/min, E2 – epinephrine infusion 90 ng/kg/min, and RW – rewarming. Data are 
presented as means and standard deviation. Significance is indicated by: * – compared with corresponding E0, # – compared with corresponding E1 (30 ng/kg/min), 
and § – compared with absolute (0 h) baseline (E0). Level of significance: p < 0.05.
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O2 Transport
DO2, VO2, and O2 ER remained unchanged at baseline in 
the NT group after 3  h (Figure  5). In the HT group, both 
cerebral DO2 and VO2 were reduced compared to prehypothermic 
baseline. Both groups showed dose-dependent increase in 
global DO2 during Epi infusion. However, cerebral O2 transport 
(cerebral DO2 and VO2) and global VO2 were not affected 




FIGURE 7 | Organ blood flow (cont.). (A,B) Heart, (C,D) kidneys, and (E,F) liver. N = 5 (NT group, left column) and n = 7 (HT group, right column). E0 – before 
epinephrine infusion, E1 – epinephrine infusion 30 ng/kg/min, E2 – epinephrine infusion 90 ng/kg/min, and RW – rewarming. Data are presented as means and 
standard deviation. Significance is indicated by: * – compared with corresponding E0, # – compared with corresponding E1 (30 ng/kg/min), and § – compared with 
absolute (0 h) baseline (E0). Level of significance: p < 0.05.
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both groups in response to 90  ng/kg/min. Cerebral O2 ER 
was reduced only in the HT group, after 30  ng/kg/
min administration.
Organ Blood Flow
Cerebellar and liver blood flow was reduced at 32°C in the 




FIGURE 8 | ECG. (A,B) QRS interval, (C,D) QTc interval, and (E,F) QRS/QTc ratio. N = 5 (NT group, left column) and n = 7 (HT group, right column). E0 – before 
epinephrine infusion, E1 – epinephrine infusion 30 ng/kg/min, E2 – epinephrine infusion 90 ng/kg/min, and RW – rewarming. Data are presented as vertical boxes 
with median (solid line), mean (dashed line), and interquartile range with 10th and 90th percentile error bars. Significance is indicated by: * – compared with 
corresponding E0, # – compared with corresponding E1 (30 ng/kg/min), and § – compared with absolute (0 h) baseline (E0). Level of significance: p < 0.05.
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Epi infusion did not induce effects on blood flow, except for 
increased kidney blood flow after 90  ng/kg/min in the NT 
group, and reduced small intestine blood flow after 90  ng/kg/
min in the HT group.
Electrocardiogram
Cooling resulted in prolongation of QRS and QTc intervals 
at baseline, while QRS/QTc decreased (Figure  8). Epi infusion 
did not have any effect on these variables.
Responses to Epi Infusion in NT Group at 
38°C After 5 h and HT Group After 
Rewarming
Hemodynamic Variables
Only dP/dtmin in the HT group changed (decreased) compared 
to its prehypothermic value (Figures  2–4). In the NT group, 
HR increased in response to 90  ng/kg/min, whereas in the 
HT group, Epi elevated HR after 30  ng/kg/min. CO increased 
in a dose-dependent manner from 30  ng/kg/min in both 
groups, while SV only increased in response to 90  ng/kg/
min. MAP remained unresponsive to Epi in both groups. 
LVSP was unaffected of Epi infusion in NT group only but 
increased after 90 ng/kg/min in the HT group. SVR reduction 
in response to Epi occurred only in the HT group during 
90  ng/kg/min. In both groups, dP/dtmax increased after 30  ng/
kg/min, while dP/dtmin and PRSW were increased only after 
90  ng/kg/min.
O2 Transport
Compared to their baseline values, cerebral O2 ER after 5  h 
baseline values was significantly reduced in both groups 
(Figure  5). All other O2 transport variables were unchanged. 
In both groups, 90  ng/kg/min caused an increase in global 
DO2, while global VO2, as well as cerebral DO2 and VO2 
remained unaltered by Epi infusion. Global O2 ER was reduced 
in response to 30  ng/kg/min in the NT group, whereas only 
after 90  ng/kg/min in the HT group. Cerebral O2 ER was 
reduced in response to 90  ng/kg/min in the NT group and 
remained unchanged in the HT group.
Organ Blood Flow
Except for increased baseline blood flow in the right temporal 
lobe and reduced liver blood flow of the HT group, no changes 
occurred from baseline (Figures  6, 7). Epi infusions did not 
alter blood flow in any organ, except for the left temporal 
lobe in the HT group, where it was increased in response to 
30  ng/kg/min.
Electrocardiogram
Only QRS/QTc ratio in the HT group was significantly reduced 
after rewarming compared to prehypothermic baseline (Figure 8). 
Epi infusion did not affect ECG parameters in the NT group. 
In the HT group, Epi infusion shortened the QTc intervals 
in response to 90  ng/kg/min. QRS interval and QRS/QTc ratio 
remained unaffected by Epi.
DISCUSSION
This study demonstrated that low- (30  ng/kg/min) and 
high- (90  ng/kg/min) dose Epi infusion provided positive 
inotropic effects, both after cooling to 32°C and subsequent 
rewarming to 38°C. We  did not find any indication that 
Epi infusion increased risk for ventricular arrhythmias 
during hypothermia.
Our previous studies using an intact rodent model have 
indicated that the beneficial hemodynamic effects of Epi are 
lost during cooling to 34°C, as administration gave a detrimental 
elevation of SVR during hypothermia (Kondratiev and Tveita, 
2006; Tveita and Sieck, 2011; Dietrichs et al., 2016). Accordingly, 
a pharmacodynamic shift toward increased α-receptor-mediated 
vasoconstriction, over the β-receptor mediated vasodilation 
and positive inotropic effects observed in normothermic 
controls, seems to exist in hypothermic rodents, even when 
administering low doses of Epi. These changes were found 
at core temperatures regularly observed in victims of accidental 
hypothermia and as induced in TTM-treated patients. 
Rewarming from accidental hypothermia is often complicated 
by HCD, while TTM-patients often suffer acute heart failure 
and need pharmacological support of cardiovascular function 
(Bernard et  al., 2002; Safar and Kochanek, 2002). In such 
patients, isolated α-receptor agonist effect of Epi infusion 
could be  treacherous, as afterload increases without 
simultaneous support of a failing heart. In the present 
experiment, however, both doses of Epi reduced SVR and 
had no significant effect on MAP, indicating that the cardiac 
and peripheral β-adrenergic effects were dominant of these 
doses, even during hypothermia. This study therefore provides 
vital information, indicating that the translational potential 
of earlier rodent findings is limited and that Epi treatment 
could be suitable in hypothermic patients at core temperatures 
≥32°C. As the pigs in the current study were not cooled to 
temperatures associated with HCD and did not have underlying 
cardiac disease, the present result advocates further studies 
exploring the effects of Epi during such pathophysiological 
conditions in pig.
In the present experiment, Epi infusion induced a dose-
dependent increase in PRSW, CO, and SV, both at 32°C and 
after rewarming. This indicates an intact effect of increasing 
cardiac inotropy through stimulating the β1-receptor – adenyl 
cyclase (AC) – cyclic AMP (cAMP) – PKA pathway during 
hypothermia. In rat studies, we found myocardial Ca2+ overload 
and increased cardiac troponin I  phosphorylation in relation 
to HCD (Wold et  al., 2013; Schaible et  al., 2016). In a failing 
heart, PKA-mediated phosphorylation of regulatory proteins 
would expectedly enhance both findings and have a negative 
impact on cardiac function. The present experiment shows 
that cardiomyocytes of pigs cooled to 32°C instead have a 
beneficial response to stimulation of the β1-receptor pathway, 
similar to normothermic animals. Moreover, we find no indication 
of a pharmacodynamic shift toward an increased peripheral 
α-receptor response and vasoconstriction, over smooth muscle 
β2-receptor stimulation and vasodilation. The dose-dependent 
Epi-induced reduction in SVR during hypothermia and 
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rewarming is similar to that in normothermic controls. 
Accordingly, high-dose Epi infusion did not increase afterload, 
in stark contrast to rodent findings during deep hypothermia 
(Dietrichs et  al., 2015).
TTM and therapeutic hypothermia are used in different 
patient groups for neuroprotection after a hypoxic insult, 
or prior to surgery with reduced cerebral perfusion (Fawaz 
and Tutunji, 1960; Dietrichs and Dietrichs, 2015). Increased 
VO2 is a well-known effect of Epi infusion (Fawaz and 
Tutunji, 1960) and could therefore be  hypothesized to have 
a negative impact in hypothermic patients. However, there 
is no indication that hypoxia is part of the pathophysiology 
underlying HCD (Kondratiev et  al., 2006). Still, Epi infusion 
could be  anticipated to alter organ blood flow, through 
unbalanced stimulation of peripheral α- and β2-receptors in 
arterioles. Yet, neither hippocampal, cerebellar nor temporal 
lobe blood flow is changed by Epi infusion during hypothermia. 
This is accompanied by absence of increased O2 demand 
during drug infusion at 32°C. High-dose Epi increased global 
DO2 in presence of unaltered global VO2, both during 
hypothermia and after rewarming, causing global as well as 
cerebral O2 ER to decrease with Epi infusion during 
hypothermia. Accordingly, Epi infusion had a positive impact 
on the ratio between cerebral supply and demand of O2 at 
32°C. Our findings therefore indicate that use of Epi to 
support cardiovascular function is suitable during TTM 
or hypothermia, as there is no suggestion of negative 
impact of Epi on the neuroprotective effect of core 
temperature reduction.
Reduction of core temperature is associated with changes 
in cardiac electrophysiology that increase risk for ventricular 
arrhythmias, which together with HCD contribute to high 
mortality of accidental hypothermia (van der Ploeg et  al., 
2010). The pathophysiological mechanism is disputed with 
much emphasis on observed J-waves that do not appear to 
be  pathognomonic for hypothermia-induced cardiac arrest 
(Dietrichs et  al., 2019, 2020a). Recent studies find that 
dispersion of repolarization and a depolarization/repolarization 
mismatch is associated with increased risk for ventricular 
fibrillation at 31–32°C (Piktel et  al., 2010; Dietrichs et  al., 
2020a). These pro-arrhythmic changes can be  detected by 
low values of a novel ECG marker for hypothermia-induced 
cardiac arrest; QRS/QTc (Dietrichs et  al., 2020b, 2021; Ref). 
Hypothermic pigs in the present study were cooled to the 
same temperature and given β1-receptor stimulating 
Epi infusions.
Due to risk for ventricular arrhythmias, Epi is considered 
to be  unfavorable in repolarization disturbances like long-QT 
syndrome (Tan et  al., 2014), which is a similar to the 
observed effects of hypothermia on cardiac electrophysiology. 
In the present experiment, we  observed a pronounced 
prolongation of the QTc interval and a parallel reduction in 
QRS/QTc values, indicating that cooling had a heterogenic 
effect on repolarization and depolarization. In rabbit hearts 
cooled to 31°C, a similar reduction in QRS/QTc values correlated 
with a 2-fold increase in risk for induction of ventricular 
fibrillation (Dietrichs et al., 2020a,b). In the present experiment, 
pigs were probably at a higher risk for developing ventricular 
arrhythmias at 32°C, compared to at 38°C before Epi infusion. 
Interestingly, neither low- or high-dose Epi appeared to increase 
risk for hypothermia-induced arrhythmias, as QRS/QTc values 
remained stable throughout infusions at 32°C. Thus, the 
electrophysiological effects of Epi do not appear to prevent 
utilization of the positive hemodynamic properties of drug 
infusion during hypothermia and rewarming, as shown in 
this study.
CONCLUSION
Administration of both 30  ng/kg/min and 90  ng/kg/min Epi 
infusion during hypothermia (32°C) produced a positive inotropic 
effect and reduced afterload in a porcine model of hypothermia 
and rewarming. The observed hemodynamic response 
corresponded with findings in the normothermic control group, 
and are different from earlier reports, reporting negative 
hemodynamic impact of catecholamine administration in 
hypothermic rodents. Further, we find no evidence of increased 
pro-arrhythmic activity after Epi infusion in hypothermic pigs. 
The results of these experiments therefore suggest that β₁-receptor 
stimulation with epinephrine is a favorable strategy for providing 
cardiovascular support in hypothermic patients, at core 
temperatures >32°C.
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